2020 Webinar: Current and Future Disease Burden of HBV: Global and Regional Perspectives

4.88 (8 votes)

Recorded On: 09/18/2020

In this on-demand webinar, representative speakers from Africa including North and Sub-Saharan Africa (Mark W. Sonderup, South Africa), East Asia (Jidong Jia, China), West and South Asia (Shiv K. Sarin, India), Europe including Western and Eastern Europe (George V. Papatheodoridis, Greece), North America (Carla Coffin, Canada) and South/Central America (Adrian Gadano) will each talk on HBV disease burden and primary challenges in their respective regions. They will present the current status and predictions for the next decade. The live question and answer session, the discussion will focus on the challenges and opportunities in each region.

Participants will be able to:

Have a global view from regional perspectives on the current situation and future prediction of HBV disease burden and to discuss the actions (most critical/effective/cost-effective) required to improve the predictions toward a more desirable goal in the region.

Promote the global outreach of AASLD by addressing issues that interest local audience.

Mark W. Sonderup

Mark Sonderup, MBChB is an associate professor in the Department of Medicine and Division of Hepatology. In 1995, he graduated from the University of Cape Town. Following his internship training, his postgraduate training was at the University of Cape Town and Groote Schuur Hospital. He obtained a Fellowship of the College of Physicians in 2002. Between 2002 and 2004, he completed a 2-year fellowship in Hepatology at the UCT/Medical Research Council Liver Research Centre and Liver Clinic at Groote Schuur Hospital, Cape Town. He briefly worked in the UK before being appointed as a Senior Specialist in the Department of Medicine and Division of Hepatology at UCT and Groote Schuur Hospital in 2007. He was granted a FRCP (London) in 2018.

Sonderup research interests include viral hepatitis and drug induced liver injuries. He assisted in co-authoring the national viral hepatitis guidelines and elimination strategy for South Africa. Currently he serves on the WHO Strategic Advisory Committee on Viral Hepatitis.

Shiv K. Sarin

Shiv K. Sarin, MD, FAASLD is the senior professor of hepatology and director of Institute of Liver and Biliary Sciences (ILBS), New Delhi. He was instrumental in setting up the Institute of Liver and Biliary Sciences, under the auspices of the Govt of Delhi. He is also the director, WHO Collaborative Centre on Chronic Liver diseases and Viral Hepatitis at ILBS. He serves as adjunct faculty, Molecular Medicine at JNU due to his deep interest and contributions to translational science. He was credited with several new treatment protocols for liver diseases, specifically variceal bleeding, liver regeneration, hepatitis B and acute-on-chronic liver failure. He has more than 620 publications to his credit, edited 13 books on liver diseases and contributed 87 chapters in various medical textbooks. He has helped develop 19 major guidelines: including six major Asian Pacific Treatment Guidelines in Liver diseases.

Sarin’s leadership roles include serving as president of the Indian Society of Gastroenterology, Indian Association for the Study of the Liver, Asian Pacific Association of Liver (APASL) and chairman steering committee of the APASL. He was awarded the prestigious 2017 Henry L. Bockus Medal by World Gastroenterology Organization. He was bestowed with Padma Bhushan by the government of India. He was a recipient of Shanti Swarup Bhatnagar Award, The World Academy of Medical Sciences (TWAS) International Prize, EASL International Recognition Award, Om Prakash Bhasin Award, Dhanvantri Medical Award, Ranbaxy Medical Sciences Award and the ‘Best Teacher’ Award. He, along with other Board of Governors, developed the ‘Vision 2015’ document for Medical Education in India during his tenure as chairman of Medical Council of India.

George V. Papatheodoridis

George Papatheodoridis, MD, PhD, FAASLD is a professor in medicine and gastroenterology at Medical School of National and Kapodistrian University of Athens and Director of the Academic Gastroenterology Department and the Liver Transplantation Unit of “Laiko” General Hospital of Athens, Greece. He is also the president of the Hellenic Transplant Organization. In October 1986, he was trained in Medicine at the Medical School of Athens University and graduated with excellence (9.2/10). In February 1996, he completed his PhD thesis at the Medical School of Athens University. He was trained in Gastroenterology at Tzaneion Hospital of Piraeus, Greece and had a two-year research fellowship in Hepatology at the Royal Free Hospital of London, UK (01/1997-01/1999).

Papatheodoridis has served in many international and national associations. He is a member of EASL and American Association for Study of Liver Diseases (AASLD fellow) and founding member and treasurer of Hepatitis B and C Public Policy Association. He is president of Hellenic Foundation of Gastroenterology and Nutrition. His main research interest has been focused on viral hepatitis. He has co-authored more than 315 papers published in PubMed journals having total IF>2000 and >1600/25000 citations (h-index 62/74) in Scopus/Google Scholar. He was an associate editor of Liver International and served as an editorial board member and reviewer of several international journals. He has given more than 160 lectures, chaired over 50 lectures/round tables and presented over 300 abstracts in international meetings.

Carla S. Coffin

Carla Coffin, MD is an associate professor of medicine (2016), Cumming School of Medicine, University of Calgary and Medical Director of the Calgary Liver Unit, Calgary Division of Gastroenterology and Hepatology, Alberta Health Services, Alberta, Canada. She received MSc degree using the woodchuck HBV model with Professor TI Michalak and MD from Memorial University of Newfoundland, NL. She completed Internal Medicine and Gastroenterology fellowship at the University of Calgary, AB followed by an American Association for the Study of Liver Disease (AASLD) Advanced Hepatology Fellowship with Professor NA Terrault at the University of California, San Francisco.

Coffin was a recipient of a Canadian Institutes of Health Research (CIHR) New Investigator Award (2012-2017). Her research has been supported by CIHR, AASLD, the American Gastroenterology Association, Canadian Foundation for Innovation / Alberta Advanced Education Technology, Alberta Innovates and Industry partners. She was first author on the 2012 and 2018 Canadian Association for the Study of the Liver (CASL) Hepatitis B guidelines and is Chair of the CASL Education Committee (2019-2021). She served on the World Health Organization (WHO) Expert Advisory Panel on Drug Evaluation (2015) and extended as on call WHO advisor until 2021. She has an active translational research program in hepatitis B with 90 peer-reviewed publications, has participated in more than 20 hepatitis B clinical trials and was integral to establishing the Canadian Hepatitis B Research Network.

Adrián C. Gadano

Adrián Gadano, MD is an associate professor in Physiology, Gastroenterology and Hepatology at the Italian Hospital School of Medicine, Argentina. He oversees the Liver Unit and Medical Director of the Transplant Unit at the Italian Hospital in Buenos Aires. He is a consultant in Gastroenterology and Hepatology and has over 25 years in the management of patients affected with hepato-biliary diseases and liver transplantation. Gadano is chief of the Research Department at the same Institution. Since the early 1990’s, he conducted, coordinated and participated in several international and national clinical trials in the fields of viral hepatitis, complications of cirrhosis, hepatocellular carcinoma and liver transplantation.

Gadano is a member of several intra-hospital and national committees, including the Argentinian Association for the Study of Liver Diseases (AAEEH), Argentinian Society of Gastroenterology (SAGE), the Argentinian Society of Transplantation (SAT). He is also a member of the Latin American Society of Liver Diseases (ALEH), the European Association of the Study of Liver Disease (EASL) and member of the board of Journal of Hepatology. He is part of the Board of the International Club of Ascitis (ICA). He was the president of the Argentinian Society of Transplantation (SAT), Argentinian Association for the Study of Liver Diseases (AAEEH) and the ICALMA Foundation. He has published over 150 original papers in official and peer-reviewed journals, and many other journal articles, book chapters and textbooks. He presented, during the last twenty years, hundreds of original papers at conferences and has chaired numerous sessions and symposia at national and international congresses.

Jidong Jia

Jidong Jia, MD, PhD, is a Hepatologist and Director of the Liver Research Centre at the Beijing Friendship Hospital, Capital University in Beijing, China. He is also immediate past President of the Chinese Society of Hepatology, Past President of APASL (2009-2010), Vice President of IASL. Dr. Jia also serves as associate editor for Journal of Gastroenterology & Hepatology, Hepatology International and Liver International. His clinical interests include the chronic viral hepatitis and autoimmune liver diseases. His research work mainly on cellular and molecular biology of the extracellular matrix of the liver and the pathogenesis and therapeutic study of experimental liver fibrosis.

Mindie H. Nguyen (Moderator)

Mindie Nguyen, MD is a professor of medicine and director for the Hepatology Fellowship and Clerkship in the Division of Gastroenterology and Hepatology and Liver Transplant at Stanford University Medical Center. She is an active clinician with a large general and transplant liver practice, and an active researcher in viral hepatitis, non-alcoholic fatty liver disease and liver cancer with over 250 publications including first or senior authorship in leading journals such as The New England Journal of Medicine, Lancet Gastroenterology and Hepatology, Gastroenterology, Journal of Hepatology and HEPATOLOGY.

Nguyen has served as editorial/advisory board member for major journals such as Lancet Gastroenterology and Hepatology, Gastroenterology and HEPATOLOGY. She is currently Chair of the Hepatitis B Special Interest Group for the American Association for the Study of Liver Diseases (AASLD) and an Officer/Treasurer and Executive Governing Council for the International Association for the Study of Liver Diseases (IASL). She is the lead Principal Investigator for several multinational studies involving over 40 centers in the U.S. and Asia Pacific. She serves as Board of Directors or Advisors for non-profit organizations locally and nationally in the U.S; and in collaboration with the local country Ministries of Health and Sports, she has directed scientific programs of continuing medical conferences for physicians in Mongolia and Myanmar. As an active teacher and educator, she has mentored over 130 trainees from high school students to undergraduate, medical, Masters’ and PhD students in Public Health/Epidemiology, clinical residents/fellows, postdoctoral research fellows, and faculty at Assistant/Associate Professor rank from Stanford University as well as other institutions in the U.S. and overseas.

Harry Janssen (Moderator)

Harry Janssen, MD, PhD, FAASLD is a professor of medicine at the University of Toronto, Ontario, Canada, where he holds the Francis Family Chair in hepatology. He currently works at Toronto General Hospital as chief of hepatology and director of the Toronto Centre for Liver Disease.

Dr. Janssen graduated from medical school in the Netherlands. During his study he spent one year as research student in Hepatology at the Mayo Clinic. He obtained his PhD in Rotterdam on the role of immune modulating therapy in hepatitis B. Following his training in Internal Medicine and Gastroenterology in the Netherlands, he returned to the Mayo Clinic for a Research Fellowship in Hepatology. In 2001, he became a faculty member and in 2006 he was appointed as full professor of medicine and chief of the Section Liver Diseases and Transplantation in Rotterdam. In 2013, he came to Canada where he merged three liver programs into the Toronto Centre for Liver Disease, based at the Toronto General Hospital, University Health Network.

Dr. Janssen has coordinated numerous clinical and translational studies on treatment for chronic viral hepatitis and other liver diseases. His main research interest is cure of chronic hepatitis B. He has published more than 500 original peer-reviewed papers and many book chapters. His H-index is over 100 and he has been cited 45,000 times (Google Scholar). He has received several prestigious international awards and has mentored over 50 PhD students, of whom many have taken leadership positions in the field of hepatology or virology.

Key:

Complete
Failed
Available
Locked
Current and Future Disease Burden of HBV: Global and Regional Perspectives
Open to view video.
Open to view video. Moderators: Mindie H. Nguyen, MD, MAS, AGAF, FAASLD and Harry Janssen, MD, PhD, FAASLD Presenters: Mark W. Sonderup, MBChB, Jidong Jia, MD, PhD, Shiv K. Sarin, MD, FAASLD, George V. Papatheodoridis, MD, PhD, FAASLD, Carla S. Coffin, MD, MSC and Adrián C. Gadano, MD
Live Q&A Panel Discussion
Open to view video.
Open to view video. Current and Future Disease Burden of HBV: Global and Regional Perspectives
Final Evaluation
Final Evaluation
4 Questions
4 Questions Please complete the following evaluation form to share your feedback on this activity.